{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:55:02Z","timestamp":1790787302281,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2020YFS0035"],"award-info":[{"award-number":["2020YFS0035"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jhin.2023.03.003","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T12:33:29Z","timestamp":1678710809000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"136","author":[{"given":"M.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2023.03.003_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26535","article-title":"Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: a 16-year tertiary single-institution experience","volume":"64","author":"Li","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jhin.2023.03.003_bib2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2014-03-560847","article-title":"Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003","volume":"124","author":"O\u2019Connor","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jhin.2023.03.003_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26909","article-title":"Treatment-related mortality in relapsed childhood acute lymphoblastic leukemia","volume":"65","author":"Oskarsson","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jhin.2023.03.003_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/pbc.24855","article-title":"Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia","volume":"61","author":"Seif","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jhin.2023.03.003_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2141.2010.08389.x","article-title":"Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984\u20132003","volume":"151","author":"Molgaard-Hansen","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhin.2023.03.003_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MPH.0b013e31822817a6","article-title":"Life-threatening and fatal infections in children with acute myeloid leukemia: a report from the Children\u2019s Oncology Group","volume":"34","author":"Sung","year":"2012","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.jhin.2023.03.003_bib7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/cncr.24107","article-title":"Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia","volume":"115","author":"Sung","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jhin.2023.03.003_bib8","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1182\/blood-2007-05-091942","article-title":"Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia","volume":"110","author":"Sung","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jhin.2023.03.003_bib9","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhin.2023.03.003_bib10","series-title":"Overview of the treatment of acute lymphoblastic leukemia\/lymphoma in children and adolescents","author":"Terzah","year":"2020"},{"key":"10.1016\/j.jhin.2023.03.003_bib11","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhin.2023.03.003_bib12","first-page":"20","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jhin.2023.03.003_bib13","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jhin.2023.03.003_bib14","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1002\/cam4.2395","article-title":"Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: a systematic review of randomized trials","volume":"8","author":"Egan","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jhin.2023.03.003_bib15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cid\/ciz1082","article-title":"Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation","volume":"71","author":"Lehrnbecher","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2023.03.003_bib16","series-title":"Acute myeloid leukemia in children and adolescents","author":"Tarlock","year":"2021"},{"key":"10.1016\/j.jhin.2023.03.003_bib17","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/INF.0b013e3182793610","article-title":"Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy","volume":"32","author":"Laoprasopwattana","year":"2013","journal-title":"J\u00a0Pediatr Infect Dis"},{"key":"10.1016\/j.jhin.2023.03.003_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood.V126.23.249.249","article-title":"Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia","volume":"126","author":"Sulis","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jhin.2023.03.003_bib19","first-page":"1","article-title":"Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia","volume":"4","author":"Widjajanto","year":"2013","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.jhin.2023.03.003_bib20","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2666-5247(20)30202-0","article-title":"Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis","volume":"2","author":"Margolis","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jhin.2023.03.003_bib21","article-title":"Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia","volume":"65","author":"Sulis","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jhin.2023.03.003_bib22","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/cid\/cix644","article-title":"Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia","volume":"65","author":"Wolf","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2023.03.003_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/pbc.22423","article-title":"Infections during induction therapy for children with acute lymphoblastic leu-kemia. The role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis","volume":"55","author":"Rungoe","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jhin.2023.03.003_bib24","first-page":"275","article-title":"Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia","volume":"48","author":"Schr\u00f8der","year":"2001","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.jhin.2023.03.003_bib25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.6004\/jnccn.2021.0042","article-title":"Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Brown","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.jhin.2023.03.003_bib26","series-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","author":"Lehrnbecher","year":"2017"},{"key":"10.1016\/j.jhin.2023.03.003_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.eimc.2019.01.013","volume":"38","author":"Gudiol","year":"2020","journal-title":"Enferm Infec Micr Cl"},{"key":"10.1016\/j.jhin.2023.03.003_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhin.2023.03.003_bib30","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jhin.2023.03.003_bib31","series-title":"The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","first-page":"1","author":"Peterson","year":"2011"},{"key":"10.1016\/j.jhin.2023.03.003_bib32","author":"Wells"},{"key":"10.1016\/j.jhin.2023.03.003_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction \u2013 GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jhin.2023.03.003_bib34","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jhin.2023.03.003_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/08880018409141739","article-title":"Trimethoprim-sulfamethoxazole and nystatin prophylaxis in children with acute lymphoblastic leukemia","volume":"1","author":"Lange","year":"1984","journal-title":"Eur Oncol Haematol"},{"key":"10.1016\/j.jhin.2023.03.003_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00725-5","article-title":"Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia","volume":"11","author":"Yeh","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhin.2023.03.003_bib38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.arcped.2018.09.012","article-title":"Effectiveness of antibacterial prophylaxis in children with acute leukemia: a report from a single institution over a 20-year period","volume":"25","author":"Chastagner","year":"2018","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.jhin.2023.03.003_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1620\/tjem.134.273","article-title":"Prophylaxis of bacterial infection by sulfamethoxazole-trimethoprim (SMX-TMP) during chemotherapy in patients with childhood acute leukemia","volume":"134","author":"Tono-oka","year":"1981","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jhin.2023.03.003_bib40","series-title":"Pediatric blood and cancer conference: 53rd annual congress of the International Society of Paediatric Oncology","article-title":"Prophylactic use of levofloxacin leads to reduction in the febrile neutropenia episodes during induction chemotherapy in children of acute lymphoblastic leukemia and lymphoblastic lymphoma","author":"Rehman","year":"2021"},{"key":"10.1016\/j.jhin.2023.03.003_bib41","series-title":"Pediatric blood and cancer conference: 52nd Congress of the International Society of Paediatric Oncology","article-title":"Effectiveness of ciprofloxacin prophylaxis during induction therapy in Mexican pediatric patients with acute lymphoblastic leukemia","volume":"67","author":"Aguilar","year":"2020"},{"key":"10.1016\/j.jhin.2023.03.003_bib42","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jsps.2018.04.002","article-title":"Antibacterial prophylaxis in pediatric patients with leukemia","volume":"26","author":"Al Omar","year":"2018","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.jhin.2023.03.003_bib43","first-page":"13","article-title":"Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials","volume":"69","author":"Kimura","year":"2014","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jhin.2023.03.003_bib44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/16078454.2019.1589706","article-title":"Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis","volume":"24","author":"Owattanapanich","year":"2019","journal-title":"Hematology"},{"key":"10.1016\/j.jhin.2023.03.003_bib45","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2023.03.003_bib46","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2023.03.003_bib47","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jhin.2023.03.003_bib48","unstructured":"University College London. CiproPAL (ciprofloxacin prophylaxis in acute leukaemia): a randomised trial to assess the use of ciprofloxacin prophylaxis to prevent bacterial infection in children treated on the induction phase of the ALL together-1 treatment protocol 2020. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04678869 [last accessed March 2023]."},{"key":"10.1016\/j.jhin.2023.03.003_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40272-022-00513-2","article-title":"Safety of quinolones in children: a systematic review and meta-analysis","volume":"24","author":"Li","year":"2022","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jhin.2023.03.003_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2016.03.008","article-title":"Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis","volume":"48","author":"Vardakas","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2023.03.003_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.441","article-title":"Clostridium difficile infection in children","volume":"167","author":"Sammons","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jhin.2023.03.003_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cit155","article-title":"Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children","volume":"57","author":"Sammons","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2023.03.003_bib53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jpids\/piu008","article-title":"Variation in risk of hospital-onset Clostridium difficile infection across \u03b2-lactam antibiotics in children with new-onset acute lymphoblastic leukemia","volume":"3","author":"Fisher","year":"2014","journal-title":"J\u00a0Pediat Infect Dis Soc"},{"key":"10.1016\/j.jhin.2023.03.003_bib54","series-title":"Abeloff\u2019s clinical oncology","first-page":"1748","article-title":"Childhood leukemia","author":"Hunger","year":"2020"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670123000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670123000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:02:37Z","timestamp":1777525357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670123000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":52,"alternative-id":["S0195670123000774"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2023.03.003","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2023.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}